The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study

Nayak, Jasmir G.; Scalzo, Nicholas; Chu, Alice; Shiff, Benjamin; Kearns, James T.; Dy, Geolani W.; Macleod, Liam C.; Mossanen, Matthew; Ellis, William; Lin, Daniel W.; Wright, Jonathan L.; True, Lawrence D.; Gore, John L.

doi:10.1038/s41391-019-0169-7

Cited by 10 publications

(16 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PILOT STUDIES AND DATA SOURCES Details of the pilot trials have been described previously and are summarized in Fig. 1 [12,13,14,15]. In brief, PCPR templates were iteratively developed for each organ site via multidisciplinary input from clinical experts (oncology, surgery, pathology), researchers, and patient advisors.…”

Section: Pilot Studies and Data Sourcesmentioning

confidence: 99%

“…Over the past seven years, our team has developed and piloted patient-centered versions of pathology reports for four cancer organ sites: prostate, bladder, breast, and colorectal polyp [12,13,14,15]. Here, we re ect on cross-pilot learnings from these four pilot trials related to barriers and facilitators of patientcentered pathology report (PCPR) implementation.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Multi-pilot implementation experiences of patient-centered pathology reports: lessons learned for the advancement of patient-centered tools for cancer decision-making

Austin

Kilgore

et al. 2023

Cancer Causes Control

Self Cite

View full text Add to dashboard Cite

New federal legislation in the United States grants patients expanded access to their medical records, making it critical that medical records information is understandable to patients. Provision of informational summaries signi cantly increase patient perceptions of patient-centered care and reduce feelings of uncertainty, yet their use for cancer pathology is limited. MethodsOur team developed and piloted patient-centered versions of pathology reports (PCPRs) for four cancer organ sites: prostate, bladder, breast, and colorectal polyp. The objective of this analysis was to identify common barriers and facilitators to support dissemination of PCPRs in care delivery settings. We analyzed quantitative and qualitative data from pilot PCPR implementations, guided by the RE-AIM framework to explore constructs of reach, effectiveness, adoption, implementation, and maintenance. ResultsWe present two case studies of PCPR implementation -breast cancer and colorectal polyps -that showcase diverse work ows for pathology reporting. Cross-pilot learnings emphasize the potential for PCPRs to improve patient satisfaction, knowledge, quality of shared decision-making activities, yet several barriers to dissemination exist. ConclusionWhile there is promise in expanding patient-centered cancer communication tools, more work is needed to expand the technological capacity for PCPRs and connect PCPRs to opportunities to reduce costs, improve quality, and reduce waste in care delivery systems.

show abstract

Section: Pilot Studies and Data Sourcesmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Multi-pilot implementation experiences of patient-centered pathology reports: lessons learned for the advancement of patient-centered tools for cancer decision-making

Austin

Kilgore

et al. 2023

Cancer Causes Control

Self Cite

View full text Add to dashboard Cite

show abstract

“…Advancing technology provides more data and risk estimates with increasingly granular detail, but how it impacts patients cannot be forgotten. Previous work 7 has shown that patient preference for narrative description and risk classification when understanding a prostate cancer diagnosis, and moving from a tierbased risk grouping system (eg, low, intermediate, high) to a continuous measurement (ie, percentage risk) might not be beneficial to all patients. As this group has previously summarised, 8 despite a plethora of currently available decision making tools there remains a high degree of uncertainty and most patients still rely on health-care providers to guide their decision making.…”

Section: Predicting Prostate Cancer-specific Mortality Using Seermentioning

confidence: 99%

Predicting prostate cancer-specific mortality using SEER

Henning

Kim

2021

The Lancet Digital Health

View full text Add to dashboard Cite

“…Patient‐centred (PC) pathology reporting has been investigated and found to be effective in improving patient understanding and experiences of receiving a diagnosis in bladder cancer and PCa 13,14 . In a study assessing the benefit after prostate biopsies, PC reports (PCRs) significantly improved Gleason score and number of positive cores recall rates 13 .…”

Section: Introductionmentioning

confidence: 99%

Patient‐centred pathology reporting improves patient experience and understanding of disease in prostate cancer care

Al Saffar,

Thomson,

Tan

et al. 2024

BJUI Compass

View full text Add to dashboard Cite

Introduction and ObjectivesPatient‐centred (PC) and holistic care improves patient satisfaction and health outcomes. We sought to investigate the benefit of utilising a PC pathology report in patients undergoing radical prostatectomy (RP) for prostate cancer (PCa). Our study aimed to evaluate and compare patient understanding of their PCa diagnosis after RP, upon receiving either a standard histopathology report or a personalised and PC report (PCR). Moreover, we evaluated knowledge retention at 4 weeks after the initial consultation.MethodsWe invited patients undergoing RP at three metropolitan Urology clinics to participate in our randomised controlled study. Patients were randomised to receive either a PCR or standard pathology report. Patient satisfaction questionnaires (Perceived Efficacy in Patient–Physician Interactions [PEPPI], Consultation and Relational Empathy [CARE] and Communication Assessment Tool [CAT]) and a knowledge test were conducted within 72 h of the initial appointment and again at 4 weeks. Accurate recollection of Gleason grade group (GGG) and extracapsular extension (ECE) were classified as ‘correct’. Baseline demographic data included age, education, marital and employment status, pre‐op prostate specific antigen (PSA) and clinical stage. Baseline data were tested for differences between groups using the Student's t test, chi‐squared test or Fisher's exact test depending on whether data were continuous, categorical or sparse. Comparison of correctly answered ‘knowledge’ questions was analysed using chi‐squared test. A significance level of p ≤ 0.05 was used.ResultsData from 62 patients were analysed (30 standard vs. 32 PCR). No significant differences in baseline demographics were found between groups. Both groups reported high levels of satisfaction with their healthcare experiences in all domains of patient–physician rapport, empathy and communication. There were no significant differences between groups in PEPPI (p = 0.68), CAT (p = 0.39) and CARE (p = 0.66) scores, at baseline and 4 weeks. Ninety‐three per cent of patients who received the PCR understood the report while 90% felt the report added to their understanding of their PCa. Regarding patient knowledge, the PCR group had significantly more correct answers on GGG and ECE as compared with the standard report group at baseline and 4 weeks (p < 0.001 and 0.001, respectively).ConclusionsOur findings demonstrate that PC pathology reports improve patient knowledge and understanding of their PCa that is retained for at least 4 weeks after initial receipt of results.

show abstract

The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study

Cited by 10 publications

References 29 publications

Multi-pilot implementation experiences of patient-centered pathology reports: lessons learned for the advancement of patient-centered tools for cancer decision-making

Multi-pilot implementation experiences of patient-centered pathology reports: lessons learned for the advancement of patient-centered tools for cancer decision-making

Predicting prostate cancer-specific mortality using SEER

Patient‐centred pathology reporting improves patient experience and understanding of disease in prostate cancer care

Contact Info

Product

Resources

About